15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 6.0% per year over the past 5 years.
Net income has grown faster than revenue (14.1% vs 6.0% per year).
Operating margin has expanded, at 64.9% in the latest year.
Free cash flow has grown 10.7% per year over the past 5 years.
Financial health
Operating income covered interest expense 24× in the latest year, up from 16× 5 years ago.
Shareholder returns
Dividends have been paid for 15 consecutive years, consuming 96.6% of earnings and 93.8% of free cash flow.
The dividend has grown 13.3% per year over the past 5 years.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$6.5B
$4.1B
0.0%
64.9%
$4.2B
—
$4.4B
2024
$6.1B
$3.5B
0.0%
64.1%
$3.6B
—
$2.9B
2023
$5.6B
$3.2B
0.0%
61.6%
$3.4B
—
$2.9B
2022
$5.0B
$2.7B
0.0%
60.1%
$3.0B
—
$2.7B
2021
$4.7B
$2.6B
0.0%
56.4%
$2.3B
—
$2.8B
2020
$4.9B
$2.1B
0.0%
54.0%
$2.5B
—
$1.6B
2019
$4.9B
$2.1B
0.0%
53.2%
$2.4B
—
$1.6B
2018
$4.3B
$2.0B
0.0%
60.5%
$2.3B
—
$1.4B
2017
$3.6B
$4.1B
0.0%
63.4%
$1.7B
—
$1.9B
2016
$3.6B
$1.5B
0.0%
61.2%
$1.6B
—
$1.9B
2015
$3.3B
$1.2B
0.0%
59.8%
$1.4B
—
$1.7B
2014
$3.1B
$1.1B
0.0%
56.8%
$1.2B
—
$1.4B
2013
$2.9B
$977M
0.0%
55.8%
$1.2B
—
$2.5B
2012
$2.9B
$896M
0.0%
58.1%
$1.1B
—
$1.6B
2011
$3.3B
$1.8B
0.0%
61.6%
$1.2B
—
$1.0B
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$1.9B
$1.2B
0.0%
69.7%
$1.2B
—
$2.4B
Dec '25
$1.6B
$1.2B
0.0%
61.8%
$1.1B
—
$4.4B
Sep '25
$1.5B
$908M
0.0%
63.3%
$950M
—
$2.4B
Jun '25
$1.7B
$1.0B
0.0%
66.7%
$1.0B
—
$2.0B
Mar '25
$1.6B
$956M
0.0%
67.5%
$1.1B
—
$1.4B
Dec '24
$1.5B
$875M
0.0%
62.1%
$992M
—
$2.9B
Sep '24
$1.6B
$913M
0.0%
64.6%
$973M
—
$2.3B
Jun '24
$1.5B
$883M
0.0%
65.3%
$759M
—
$1.8B
Mar '24
$1.5B
$855M
0.0%
64.5%
$873M
—
$1.4B
Dec '23
$1.4B
$815M
0.0%
60.0%
$1.0B
—
$2.9B
Sep '23
$1.3B
$750M
0.0%
61.3%
$837M
—
$2.3B
Jun '23
$1.4B
$778M
0.0%
61.7%
$630M
—
$1.9B
Mar '23
$1.4B
$884M
0.0%
63.4%
$887M
—
$1.6B
Dec '22
$1.2B
$638M
0.0%
55.3%
$957M
—
$2.7B
Sep '22
$1.2B
$680M
0.0%
60.2%
$634M
—
$2.1B
Jun '22
$1.2B
$663M
0.0%
60.6%
$600M
—
$1.9B
Mar '22
$1.3B
$711M
0.0%
63.8%
$776M
—
$2.0B
Dec '21
$1.1B
$625M
0.0%
55.1%
$641M
—
$2.8B
Sep '21
$1.1B
$926M
0.0%
55.3%
$600M
—
$1.5B
Jun '21
$1.2B
$511M
0.0%
57.2%
$460M
—
$1.1B
Valuation over time
How the market has priced CME against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 25.6× (Mar '23) to 19.9× (Jun '26).
The price-to-sales ratio has fallen from 13.7× (Mar '23) to 12.4× (Jun '26).
The dividend yield has risen from 3.8% (Mar '23) to 4.9% (Jun '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is CME growing its revenue and profit?
Over the past 5 years, CME Group's revenue has grown 6.0% per year, and net income grown 14.1% per year. These are computed facts, not advice.
How much debt does CME have?
As of FY2025, CME Group reported — of total debt against $4.4B of cash; operating income covered interest expense 24×.
What is CME's profit margin?
In FY2025, gross margin was —, operating margin 64.9%, and net margin 62.5%.
What is CME's P/E ratio?
As of Jun '26, CME Group traded at a price-to-earnings ratio of about 19.9× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.